AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 3 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 6 | -90.8% | 0.00% | – |
| Q4 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,958,000 | 100.00% |
| NEA Management Company, LLC | 16,362,694 | $47,452,000 | 2.11% |
| Prosight Management, LP | 1,043,550 | $3,026,000 | 1.90% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,797,000 | 1.51% |
| RA Capital Management | 5,062,759 | $14,682,000 | 1.12% |
| X-Square Capital, LLC | 231,434 | $671,000 | 0.71% |
| 683 Capital Management, LLC | 2,500,000 | $7,250,000 | 0.64% |
| Avoro Capital Advisors LLC | 3,231,893 | $9,372,000 | 0.45% |
| EAM Global Investors LLC | 244,768 | $710,000 | 0.37% |
| Polar Capital LLP | 7,877,429 | $22,845,000 | 0.23% |